| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 903 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 719 | 2021 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 283 | 2021 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 207 | 2021 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 164 | 2021 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 142 | 2021 |
| A prenylated dsRNA sensor protects against severe COVID-19 A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ... Science 374 (6567), eabj3624, 2021 | 141 | 2021 |
| IL-17–high asthma with features of a psoriasis immunophenotype J Östling, M van Geest, JPR Schofield, Z Jevnikar, S Wilson, J Ward, ... Journal of Allergy and Clinical Immunology 144 (5), 1198-1213, 2019 | 99 | 2019 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 95 | 2021 |
| Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ... The Lancet Rheumatology 3 (7), e498-e506, 2021 | 87 | 2021 |
| Stratification of asthma phenotypes by airway proteomic signatures JPR Schofield, D Burg, B Nicholas, F Strazzeri, J Brandsma, D Staykova, ... Journal of Allergy and Clinical Immunology 144 (1), 70-82, 2019 | 71 | 2019 |
| Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study DB Hawcutt, B Francis, DF Carr, AL Jorgensen, P Yin, N Wallin, N O'Hara, ... The Lancet Respiratory Medicine 6 (6), 442-450, 2018 | 71 | 2018 |
| TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity S Thiesen, P Yin, AL Jorgensen, JE Zhang, V Manzo, L McEvoy, C Barton, ... Pharmacogenetics and genomics 27 (6), 213-222, 2017 | 70 | 2017 |
| The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... Iscience 24 (11), 2021 | 62 | 2021 |
| Shared genetic risk factors across carbamazepine‐induced hypersensitivity reactions P Nicoletti, S Barrett, L McEvoy, AK Daly, G Aithal, MI Lucena, RJ Andrade, ... Clinical Pharmacology & Therapeutics 106 (5), 1028-1036, 2019 | 60 | 2019 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 59 | 2023 |
| Pharmacogenomics of NSAID-induced upper gastrointestinal toxicity L McEvoy, DF Carr, M Pirmohamed Frontiers in pharmacology 12, 684162, 2021 | 50 | 2021 |
| Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort P Nicoletti, DF Carr, S Barrett, L Mcevoy, PS Friedmann, NH Shear, ... Journal of Allergy and Clinical Immunology 147 (5), 1830-1837. e15, 2021 | 41 | 2021 |
| Identification of organ-enriched protein biomarkers of acute liver injury by targeted quantitative proteomics of blood in acetaminophen-and carbon-tetrachloride-treated mouse … S Qin, Y Zhou, L Gray, U Kusebauch, L McEvoy, DJ Antoine, L Hampson, ... Journal of proteome research 15 (10), 3724-3740, 2016 | 35 | 2016 |
| Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study F Närhi, SR Moonesinghe, SD Shenkin, TM Drake, RH Mulholland, ... The Lancet Digital Health 4 (4), e220-e234, 2022 | 26 | 2022 |
